Cormedix Inc (CRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Net Revenue (Q4 2025): $128.6 million. DefenCAF Revenue (Q4 2025): $91.2 million. Total Revenue (Full Year 2025): $401.3 million. DefenCAF Revenue (Full Year 2025): $258.8 million. Operating Expenses (Q4 2025): $48.2 million. Net Income (Q4 2025): $14 million. Pre-tax Income (Q4 2025): $56.4 million. Adjusted EBITDA (Q4 2025): $77.2 million. Cash and Cash Equivalents (End of Q4 2025): $148.5 million. 2026 Revenue Guidance: $300 to $320 million. 2026 Adjusted EBITDA Guidance: $100 to $125 million. Warning! GuruFocus has detected 7 Warning Signs with CRMD. Is CRMD fairly valued? Test your thesis with our free DCF calculator. Release Date: March 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Cormedix Inc ( NASDAQ:CRMD ) achieved peak sales of just under $260 million in 2025, highlighting strong revenue performance. The acquisition of
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026GlobeNewswire
CRMD
Earnings
- 3/5/26 - Miss
CRMD
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/6/26 - Form 4
- CRMD's page on the SEC website